Advances in Orphan Nuclear Receptor Pharmacology: A New Era in Drug Discovery | Zendy

Ian Mitchelle S. de Vera | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Advances in Orphan Nuclear Receptor Pharmacology: A New Era in Drug Discovery

Author(s) -

Ian Mitchelle S. de Vera

Publication year - 2018

Publication title -

acs pharmacology and translational science

Language(s) - Italian

Resource type - Journals

SCImago Journal Rank - 2.271

H-Index - 10

ISSN - 2575-9108

DOI - 10.1021/acsptsci.8b00029

Subject(s) - drug discovery , nuclear receptor , neuron derived orphan receptor 1 , drug development , function (biology) , computational biology , mechanism (biology) , biology , orphan drug , molecular pharmacology , pharmacology , receptor , drug , neuroscience , bioinformatics , microbiology and biotechnology , gene , genetics , transcription factor , physics , quantum mechanics

Over the past decade, advances in biophysical chemistry, genomic analysis, and structural biology have resulted in the exponential growth of knowledge and critical insight into the function and regulation of orphan nuclear receptors. This article summarizes the current progress in illuminating the structure, function, and regulation of orphan nuclear receptors and their involvement in the physiology, development and molecular mechanism of different pathological conditions. Moreover, current strategies for discovering endogenous ligands, downstream NR-regulated target genes, and new drugs for future therapeutics will be discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research